Physician profile
Sandy S Reed
NPI 1336148261
$982.14
in general payments reported to CMS, 2019-2025
17 companies · $59.18 in 2025
The $59.18 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $103 · 2021: $70.38 · 2022: $221 · 2023: $195 · 2024: $66.63 · 2025: $59.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $204.84 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $168.03 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $153.59 | 2019-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $59.03 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $51.59 | 2024 | Qelbree |
| Corium, LLC | $48.68 | 2022-2023 | Azstarys |
| Rhodes Pharmaceuticals L.P. | $44.60 | 2019 | |
| Aytu Biopharma, INC. | $37.30 | 2022-2023 | Karbinal |
| Sobi, INC | $33.25 | 2021-2023 | |
| Kaleo, INC. | $31.34 | 2019-2022 | |
| Adlon Therapeutics L.P. | $27.18 | 2019-2020 | |
| Neos Therapeutics, LP | $25.66 | 2020-2022 | |
| Glaxosmithkline, LLC. | $24.31 | 2019-2020 | |
| Pfizer INC. | $23.97 | 2019-2023 | |
| Biomarin Pharmaceutical INC. | $18.34 | 2025 | Voxzogo 1.2mg |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17.00 | 2025 | |
| Seqirus USA INC | $13.43 | 2023 | Flucelvax Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.